SCHEMBL29254451

SCHEMBL29254451

COc1ccc(-c2nn(-c3ccc4c(c3)CCNC4)c3c2cnc2ccccc23)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.56
▸ LMNA P02545 3/20 0.48
▸ PDE4A P27815 2/20 0.45
▸ PDE4B Q07343 2/20 0.45
▸ PDE4C Q08493 2/20 0.45
▸ PDE4D Q08499 2/20 0.45
▸ TP53 P04637 4/20 0.41
▸ POLB P06746 2/20 0.41
▸ TLR9 Q9NR96 1/20 0.40
▸ TLR8 Q9NR97 1/20 0.40
▸ TLR7 Q9NYK1 1/20 0.40
▸ CD274 Q9NZQ7 1/20 0.38
▸ PIK3CD O00329 1/20 0.38
▸ PIK3CA P42336 1/20 0.38
▸ PIK3CB P42338 1/20 0.38
▸ MTOR P42345 1/20 0.38
▸ PIK3CG P48736 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30951538 1.00 MAPT (0.56) MAPTLMNAPDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL30951589 0.99 MAPT (0.55) MAPTLMNAPDE4APDE4BPDE4C
SCHEMBL29254428 0.97 MAPT (0.56) MAPTLMNAPDE4APDE4BPDE4C
SCHEMBL30951540 0.97 MAPT (0.56) MAPTLMNAPDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL30951569 0.96 MAPT (0.55) MAPTLMNAPDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL29254471 0.96 MAPT (0.55) MAPTLMNAPDE4APDE4BPDE4C
SCHEMBL30951513 0.93 MAPT (0.60) MAPTLMNAPDE4APDE4BPDE4C
SCHEMBL29254463 0.93 MAPT (0.60) MAPTLMNAPDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL30951585 0.92 MAPT (0.59) MAPTLMNAPDE4APDE4BPDE4C
SCHEMBL30951530 0.90 MAPT (0.59) MAPTLMNAPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF LOMOND THERAPEUTICS, INC. 2025-01-09 — — US claimed
CN-118076605-A Substituted 1H-pyrazolo [4,3-c ] quinolines, methods of preparation and uses thereof 洛蒙治疗公司 2024-05-24 — — CN claimed
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF LOMOND THERAPEUTICS, INC. 2025-01-09 — — US disclosed
CN-118076605-A Substituted 1H-pyrazolo [4,3-c ] quinolines, methods of preparation and uses thereof 洛蒙治疗公司 2024-05-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF FLT3, PDXK, PHKG1 MAPT 4680/4885LMNA 2950/4885PDE4A 1567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback